E093 Real-life switching from infliximab innovator (Remicade) to biosimilar (Inflectra) in patients with various rheumatic diseases: a 6-month single-centre prospective observational study
- 1 April 2019
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 58 (Supplement)
- https://doi.org/10.1093/rheumatology/kez110.091